Lam Research (NASDAQ:LRCX) Trading Up 1.7% After Dividend Announcement

Lam Research Corporation (NASDAQ:LRCX) rose 1.7% during mid-day trading on Thursday following a dividend announcement from the company. The stock traded as high as $215.85 and last traded at $213.31. Approximately 10,677,981 shares changed hands during mid-day trading, a decline of 25% from the average daily volume of 14,199,229 shares. The stock had previously closed at $209.78.

The newly announced dividend which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on LRCX shares. HSBC increased their target price on shares of Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $320.00 target price (up previously from $265.00) on shares of Lam Research in a report on Thursday, January 29th. Citic Securities lifted their target price on Lam Research from $165.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Rothschild & Co Redburn increased their price target on Lam Research from $225.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Berenberg Bank boosted their price objective on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $244.57.

Lam Research Stock Up 8.3%

The firm has a market cap of $288.48 billion, a price-to-earnings ratio of 47.34, a price-to-earnings-growth ratio of 2.31 and a beta of 1.78. The stock’s 50 day moving average is $194.38 and its 200 day moving average is $150.30. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam announced a strategic alliance with CEA‑Leti and an internal leadership shift aimed at accelerating AI‑equipment development — investors see this as direct exposure to faster AI capex cycles. Lam Research Targets AI Growth With CEA Leti Deal And Leadership Shift
• Positive Sentiment: Celebrity investor/TV host Jim Cramer publicly endorsed adding LRCX to portfolios, raising retail/institutional interest and trading flows. Lam Research (LRCX) Is the Future, Says Jim Cramer
• Positive Sentiment: Argus and other analysts lifted price targets (Argus to $280) and the sell‑side average implies roughly 30% upside — upgrades and higher targets support buying interest. Argus Increases Lam Research Price Target to $280.00
• Positive Sentiment: Lam declared a $0.26 quarterly dividend (0.5% yield) — modest cash return but signals board confidence in cash flow and capital allocation. Lam Research Corporation Declares Quarterly Dividend
• Neutral Sentiment: Zacks and other screens highlight LRCX as a momentum pick amid recent market weakness — this flags participation from quant/momentum funds but also exposes the stock to volatility in a tech selloff. 3 Momentum Anomaly Stocks to Buy as Tech Rout Spooks Markets
• Neutral Sentiment: Company announced a board addition and COO transition — governance/leadership updates that deserve monitoring but aren’t an immediate revenue driver. Lam Research Announces Board Addition and COO Transition
• Negative Sentiment: Shares had a sharp pullback earlier in the week (noted as “down 10% in two days”), reflecting broader tech/crypto volatility — that recent selling created a short-term risk that some traders are buying into. Down 10 In Two Days, Is Lam Research A Good Buy?

Insider Buying and Selling at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

A number of hedge funds have recently made changes to their positions in LRCX. PMV Capital Advisers LLC acquired a new stake in shares of Lam Research during the 4th quarter valued at $25,000. IMG Wealth Management Inc. acquired a new stake in Lam Research during the second quarter valued at $26,000. Stance Capital LLC acquired a new stake in Lam Research during the third quarter valued at $26,000. Howard Hughes Medical Institute purchased a new position in Lam Research in the second quarter valued at about $27,000. Finally, Triumph Capital Management acquired a new position in Lam Research in the 3rd quarter worth about $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.